Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study

NCT02351726 is registered in ClinicalTrials.gov with LivaNova as lead sponsor.

NCT NCT02351726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02351726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitroflow Aortic Pericardial Heart Valve With Phospholipid Reduction Treatment Post Approval Study
Lead sponsor
LivaNova
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2015
Completion date
December 31, 2019
Enrollment
186 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

aortic regurgitation, aortic stenosis, aortic valve insufficiency, cardiovascular abnormalities, cardiovascular diseases, congenital abnormalities, heart diseases, heart valve diseases, pathological conditions, anatomical